Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 1, 2023

Study Completion Date

June 30, 2023

Conditions
Type 1 Diabetes
Interventions
OTHER

Test to induce a decline in plasma glucose

Participants will be admitted at the research center at 7:00 after an overnight fast. A venous catheter will be inserted into an arm vein for blood sampling purposes. A subcutaneous insulin bolus will be administered to bring plasma glucose to the glycemic threshold. Oral carbohydrates (16g) will be given when plasma glucose levels are at the target threshold. Sixty minutes after carbohydrates consumption, a standardized meal will be provided and participants will be discharged 90 minutes after the meal.

DEVICE

Dexcom G6

Participants will have to wear a Dexcom G6 during study interventions

OTHER

Dex4

When the glycemic threshold is reach, participants will be given 16g of Dex4

DRUG

Insulin

A subcutaneous insulin bolus will be given to induce a decline in plasma glucose and reach the glycemic threshold.

Trial Locations (1)

H2W 1R7

Montreal Clinical Research Institute, Montreal

All Listed Sponsors
lead

Institut de Recherches Cliniques de Montreal

OTHER